More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate
Health Law Advisor
MAY 22, 2023
1339) reflects the overarching legislative push by members from both sides of the aisle and chambers of Congress to address drug pricing issues through federal fixes to the PBM framework. Other provisions in the legislation are similar to policy proposals to regulate PBM activity in other payor markets, such as Medicaid.
Let's personalize your content